- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Asymmetrex
Asymmetrex is listed as a new startup research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: New startup
Biomarkers
- Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
- Stem Cell Analysis Assess hematopoietic, neural and mesenchymal cell progenitor proliferation and differentiation.
Cell Culture and Characterization
- Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
- Cell Culture Culture primary or immortalized cell lines.
- Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.
Clinical Consulting
- Cell Services Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...
Clinical Trials
- Clinical Research Services Determine the safety and effectiveness of medications and medical devices.
- Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
Developmental and Reproductive Toxicology (DART)
- Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.
In Vitro Toxicology
- Cytotoxicity Test for effects on cell viability and proliferation
- Hematopoietic Cell Toxicity Examine cytotoxic effects of pre-clinical compounds or biologics on adult stem cells.
Pharmacovigilance
- GxP Compliance Monitoring Ensure products or services adhere to a set minimum standard.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
Asymmetrex offers the first technology for specific counting of adult tissue stem cells from any mammalian tissue, with particular application to therapeutic human tissue stem cells. The company's AlphaSTEM Test contract service provides, for the first time, the means 1) to determine the dose and quality of therapeutic tissue stem cell preparations; 2) to monitor expansion of therapeutic tissue stem cells (e.g., mesenchymal stem cells) and design procedures that increase their expansion with reduced time and cost; 3) for inexpensive early detection of stem cell-toxic drug candidates that...
Show the full description
Asymmetrex offers the first technology for specific counting of adult tissue stem cells from any mammalian tissue, with particular application to therapeutic human tissue stem cells. The company's AlphaSTEM Test contract service provides, for the first time, the means 1) to determine the dose and quality of therapeutic tissue stem cell preparations; 2) to monitor expansion of therapeutic tissue stem cells (e.g., mesenchymal stem cells) and design procedures that increase their expansion with reduced time and cost; 3) for inexpensive early detection of stem cell-toxic drug candidates that cause chronic organ failure; 4) to identify tissue stem cell-active agents; and 5) to quantify tissue stem cell number in research experiments.
- Professional associations
- MassBio
- Website
- asymmetrex.com
Supplier diversity
SAM.gov small-business designations
US small-business federal-contractor designation, self-certified in the U.S. federal System for Award Management (SAM.gov). Coverage is limited to matched U.S. small-business suppliers, so an absent designation is not evidence of its absence.
Work with Asymmetrex on Scientist.com
For prices, more details, or to contact Asymmetrex, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.